• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GALDERMA Q-MED RESTYLANE; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GALDERMA Q-MED RESTYLANE; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Lot Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Necrosis (1971); Pain (1994); Swelling (2091); Tingling (2171); No Code Available (3191)
Event Date 01/30/2018
Event Type  Injury  
Manufacturer Narrative
Lot number was not reported.Pharmacovigilance comment: the serious events of cutaneous contour deformity, necrosis and abscess at the implant site and the non-serious events of paraesthesia, swelling and pain at the implant site were considered expected and possibly related to the treatment.Serious criteria includes the need for medical and surgical intervention including abscess removal and permanent damage.The cutaneous contour deformity was likely due to scarring and defects secondary to necrosis.Potential contributory factor include injection technique or improper aseptic precautions.The case meets the criteria for expedited reporting to the regulatory authorities.Capa comment: the information in this single case does not suggest involvement of a nonconforming product or quality problem and will not initiate a corrective or preventive action.
 
Event Description
Case reference number (b)(4) is a spontaneous report sent on 18-oct-2019 by a (b)(6) female patient concerning herself.The patient medical history included seasonal allergies.The patient had previously received treatment with restylane on 2017.Concomitant treatment included zyrtec [zyrtec] as needed for seasonal allergies.On (b)(6) 2018, the patient received treatment with restylane to lips (unknown amount, lot number, needle type and injection technique).On (b)(6) 2018, immediately after treatment the patient experienced tingling/loss of feeling (implant site paraesthesia) at lips, increased swelling (implant site swelling), right lower lip was the size of a baseball and was painful (implant site pain).On (b)(6) 2018, the patient visited the urgent care and prescribed prednisone [prednisone], which did not help with the swelling.On an unknown date in 2018, the patient developed abscess (implant site abscess) and necrosis (implant site necrosis) at lip.On (b)(6) 2018, the patient visited the emergency room, and had undergone an abscess removal on the area.The patient was also prescribed an unspecified antibiotics.The patient reported that the swelling and pain had subsided.The patient was left with no feeling in her right lower lip and there was a dip in skin (cutaneous contour deformity) where the necrotic tissue was removed.Outcome at the time of the report: necrosis was recovering/resolving.Abscess was recovered/resolved.Dip in skin was not recovered/not resolved.Tingling/loss of feeling was not recovered/not resolved.Swelling was recovered/resolved.Pain was recovered/resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESTYLANE
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
GALDERMA Q-MED
seminariegatan 21
uppsala, se-752 28
SW 
Manufacturer (Section G)
GALDERMA Q-MED
seminariegatan 21
uppsala, se-752 28
SW  
Manufacturer Contact
amy poteate
14501 north freeway
fort worth, TX 76177
8175615353
MDR Report Key9318019
MDR Text Key185555296
Report Number9710154-2019-00103
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 11/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/13/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received10/18/2019
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Disability;
Patient Age33 YR
-
-